Laryngeal dysplasia, demographics, and treatment: A single-institution, 20-year review

Selmin Karatayli-Ozgursoy, Paulette Pacheco-Lopez, Alexander T. Hillel, Simon R. Best, Justin A. Bishop, Lee M. Akst

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

IMPORTANCE: Laryngeal dysplasia is a common disease entity that remains clinically frustrating because functional outcomes are balanced against oncologic results. Understanding evolution in dysplasia demographics, treatment, and progression ratesmay inform better therapy in the future. OBJECTIVES: To review laryngeal dysplasia cases at a single institution during the last 20 years and identify changes in patient demographics, categorize treatment approaches, and review rates of progression to cancer. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective medical record review, patients with laryngeal dysplasia treated at an academic medical center were identified on review of pathology records. INTERVENTIONS Patients were organized by date of dysplasia diagnosis, divided into 2 groups (group 1, January 1, 1993, through December 31, 2002; group 2, January 1, 2003, through December 31, 2012), and compared against one another. MAIN OUTCOMES AND MEASURES: Age at diagnosis, sex, type of treatment, and progression to malignant disease were analyzed from one period to the next. RESULTS: A total of 107 patients were identified through review of pathology databases. Progression of dysplasia to cancer remained roughly stable across periods, at 8.8% and 8.0%, respectively. Mean age at diagnosis decreased from 68.7 to 61.7 years over time, with a statistically significant trend toward presentation at younger ages. The male to female ratio was 3.75 in group 1 and 3.17 in group 2, with a trend toward a greater proportion of females over time that did not reach statistical significance. Use of radiotherapy remained stable across groups, with increased use of microflap excision techniques and laser treatment (especially photoangiolytic lasers) in group 2. CONCLUSIONS AND RELEVANCE: Overall, progression of laryngeal dysplasia to cancer has remained stable during the past 20 years at a rate of approximately 8%. Although laryngeal dysplasia remains a disease predominantly found in males, there is a demographic trend toward diagnosis at earlier ages. Treatment choicesmay slowly be changing over time, although multi-institutional studiesmay be required to better categorize this shift.

Original languageEnglish (US)
Pages (from-to)313-318
Number of pages6
JournalJAMA Otolaryngology - Head and Neck Surgery
Volume141
Issue number4
DOIs
StatePublished - Jan 1 2015

Fingerprint

Demography
Lasers
Therapeutics
Pathology
Neoplasms
Medical Records
Radiotherapy
Databases

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery
  • Medicine(all)

Cite this

Laryngeal dysplasia, demographics, and treatment : A single-institution, 20-year review. / Karatayli-Ozgursoy, Selmin; Pacheco-Lopez, Paulette; Hillel, Alexander T.; Best, Simon R.; Bishop, Justin A.; Akst, Lee M.

In: JAMA Otolaryngology - Head and Neck Surgery, Vol. 141, No. 4, 01.01.2015, p. 313-318.

Research output: Contribution to journalArticle

Karatayli-Ozgursoy, Selmin ; Pacheco-Lopez, Paulette ; Hillel, Alexander T. ; Best, Simon R. ; Bishop, Justin A. ; Akst, Lee M. / Laryngeal dysplasia, demographics, and treatment : A single-institution, 20-year review. In: JAMA Otolaryngology - Head and Neck Surgery. 2015 ; Vol. 141, No. 4. pp. 313-318.
@article{07641375372d4a2fbfc9823217c091a8,
title = "Laryngeal dysplasia, demographics, and treatment: A single-institution, 20-year review",
abstract = "IMPORTANCE: Laryngeal dysplasia is a common disease entity that remains clinically frustrating because functional outcomes are balanced against oncologic results. Understanding evolution in dysplasia demographics, treatment, and progression ratesmay inform better therapy in the future. OBJECTIVES: To review laryngeal dysplasia cases at a single institution during the last 20 years and identify changes in patient demographics, categorize treatment approaches, and review rates of progression to cancer. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective medical record review, patients with laryngeal dysplasia treated at an academic medical center were identified on review of pathology records. INTERVENTIONS Patients were organized by date of dysplasia diagnosis, divided into 2 groups (group 1, January 1, 1993, through December 31, 2002; group 2, January 1, 2003, through December 31, 2012), and compared against one another. MAIN OUTCOMES AND MEASURES: Age at diagnosis, sex, type of treatment, and progression to malignant disease were analyzed from one period to the next. RESULTS: A total of 107 patients were identified through review of pathology databases. Progression of dysplasia to cancer remained roughly stable across periods, at 8.8{\%} and 8.0{\%}, respectively. Mean age at diagnosis decreased from 68.7 to 61.7 years over time, with a statistically significant trend toward presentation at younger ages. The male to female ratio was 3.75 in group 1 and 3.17 in group 2, with a trend toward a greater proportion of females over time that did not reach statistical significance. Use of radiotherapy remained stable across groups, with increased use of microflap excision techniques and laser treatment (especially photoangiolytic lasers) in group 2. CONCLUSIONS AND RELEVANCE: Overall, progression of laryngeal dysplasia to cancer has remained stable during the past 20 years at a rate of approximately 8{\%}. Although laryngeal dysplasia remains a disease predominantly found in males, there is a demographic trend toward diagnosis at earlier ages. Treatment choicesmay slowly be changing over time, although multi-institutional studiesmay be required to better categorize this shift.",
author = "Selmin Karatayli-Ozgursoy and Paulette Pacheco-Lopez and Hillel, {Alexander T.} and Best, {Simon R.} and Bishop, {Justin A.} and Akst, {Lee M.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1001/jamaoto.2014.3736",
language = "English (US)",
volume = "141",
pages = "313--318",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Laryngeal dysplasia, demographics, and treatment

T2 - A single-institution, 20-year review

AU - Karatayli-Ozgursoy, Selmin

AU - Pacheco-Lopez, Paulette

AU - Hillel, Alexander T.

AU - Best, Simon R.

AU - Bishop, Justin A.

AU - Akst, Lee M.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - IMPORTANCE: Laryngeal dysplasia is a common disease entity that remains clinically frustrating because functional outcomes are balanced against oncologic results. Understanding evolution in dysplasia demographics, treatment, and progression ratesmay inform better therapy in the future. OBJECTIVES: To review laryngeal dysplasia cases at a single institution during the last 20 years and identify changes in patient demographics, categorize treatment approaches, and review rates of progression to cancer. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective medical record review, patients with laryngeal dysplasia treated at an academic medical center were identified on review of pathology records. INTERVENTIONS Patients were organized by date of dysplasia diagnosis, divided into 2 groups (group 1, January 1, 1993, through December 31, 2002; group 2, January 1, 2003, through December 31, 2012), and compared against one another. MAIN OUTCOMES AND MEASURES: Age at diagnosis, sex, type of treatment, and progression to malignant disease were analyzed from one period to the next. RESULTS: A total of 107 patients were identified through review of pathology databases. Progression of dysplasia to cancer remained roughly stable across periods, at 8.8% and 8.0%, respectively. Mean age at diagnosis decreased from 68.7 to 61.7 years over time, with a statistically significant trend toward presentation at younger ages. The male to female ratio was 3.75 in group 1 and 3.17 in group 2, with a trend toward a greater proportion of females over time that did not reach statistical significance. Use of radiotherapy remained stable across groups, with increased use of microflap excision techniques and laser treatment (especially photoangiolytic lasers) in group 2. CONCLUSIONS AND RELEVANCE: Overall, progression of laryngeal dysplasia to cancer has remained stable during the past 20 years at a rate of approximately 8%. Although laryngeal dysplasia remains a disease predominantly found in males, there is a demographic trend toward diagnosis at earlier ages. Treatment choicesmay slowly be changing over time, although multi-institutional studiesmay be required to better categorize this shift.

AB - IMPORTANCE: Laryngeal dysplasia is a common disease entity that remains clinically frustrating because functional outcomes are balanced against oncologic results. Understanding evolution in dysplasia demographics, treatment, and progression ratesmay inform better therapy in the future. OBJECTIVES: To review laryngeal dysplasia cases at a single institution during the last 20 years and identify changes in patient demographics, categorize treatment approaches, and review rates of progression to cancer. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective medical record review, patients with laryngeal dysplasia treated at an academic medical center were identified on review of pathology records. INTERVENTIONS Patients were organized by date of dysplasia diagnosis, divided into 2 groups (group 1, January 1, 1993, through December 31, 2002; group 2, January 1, 2003, through December 31, 2012), and compared against one another. MAIN OUTCOMES AND MEASURES: Age at diagnosis, sex, type of treatment, and progression to malignant disease were analyzed from one period to the next. RESULTS: A total of 107 patients were identified through review of pathology databases. Progression of dysplasia to cancer remained roughly stable across periods, at 8.8% and 8.0%, respectively. Mean age at diagnosis decreased from 68.7 to 61.7 years over time, with a statistically significant trend toward presentation at younger ages. The male to female ratio was 3.75 in group 1 and 3.17 in group 2, with a trend toward a greater proportion of females over time that did not reach statistical significance. Use of radiotherapy remained stable across groups, with increased use of microflap excision techniques and laser treatment (especially photoangiolytic lasers) in group 2. CONCLUSIONS AND RELEVANCE: Overall, progression of laryngeal dysplasia to cancer has remained stable during the past 20 years at a rate of approximately 8%. Although laryngeal dysplasia remains a disease predominantly found in males, there is a demographic trend toward diagnosis at earlier ages. Treatment choicesmay slowly be changing over time, although multi-institutional studiesmay be required to better categorize this shift.

UR - http://www.scopus.com/inward/record.url?scp=84928476288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928476288&partnerID=8YFLogxK

U2 - 10.1001/jamaoto.2014.3736

DO - 10.1001/jamaoto.2014.3736

M3 - Article

C2 - 25654369

AN - SCOPUS:84928476288

VL - 141

SP - 313

EP - 318

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 4

ER -